(Q33276227)

English

Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

0 references

0 references

dasatinib monohydrate

1 reference

based on heuristic

inferred from title

alveolar soft part sarcoma

1 reference

based on heuristic

inferred from title

epithelioid sarcoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Margaret von Mehren

10

object named as

Margaret von Mehren

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Scott M Schuetze

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Vanessa Bolejack

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Edwin Choy

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Kristen N Ganjoo

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Arthur P Staddon

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Warren A Chow

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Hussein A Tawbi

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Brian L Samuels

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Shreyaskumar R Patel

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Gina D'Amato

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Kirsten M Leu

12

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

David M Loeb

13

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Charles A Forscher

14

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Mohammed M Milhem

15

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Daniel A Rushing

16

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

David R Lucas

17

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Rashmi Chugh

18

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Denise K Reinke

19

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Laurence H Baker

20

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

3 October 2016

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

123

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

90-97

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Alveolar soft part sarcoma: clinical presentation, treatment, and outcome in a series of 33 patients at a single institution.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Epithelioid sarcoma: one institution's experience with a rare sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Cediranib for metastatic alveolar soft part sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Sunitinib malate in solitary fibrous tumor (SFT).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Phase II study of imatinib in advanced chordoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Phase I dose-escalation and pharmacokinetic study of dasatinib in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Imatinib in advanced chordoma: A retrospective case series analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Phase II study on lapatinib in advanced EGFR-positive chordoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Role of palliative chemotherapy in advanced epithelioid sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Gemcitabine and docetaxel for epithelioid sarcoma: results from a retrospective, multi-institutional analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

21 January 2018

Hemangiopericytoma: a 20-year single-institution experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30379

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.30379

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33276227&oldid=1964261432"